Peter T Sawicki

Summary

Country: Germany

Publications

  1. ncbi request reprint Have ALLHAT, ANBP2, ASCOT-BPLA, and so forth improved our knowledge about better hypertension care?
    Peter T Sawicki
    Institute for Quality and Efficiency in Health Care, Cologne, Germany
    Hypertension 48:1-7. 2006
  2. ncbi request reprint [Assessment of the number of cardio- and cerebrovascular events due to rofecoxib (Vioxx) in Germany between 2001 and 2004]
    Peter T Sawicki
    Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen IQWiG, Koln
    Med Klin (Munich) 101:191-7. 2006
  3. ncbi request reprint [Quality of health care in Germany. A six-country comparison]
    Peter T Sawicki
    Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen IQWiG, Koln
    Med Klin (Munich) 100:755-68. 2005
  4. ncbi request reprint [Donepezil in patients with Alzheimer's disease--a critical appraisal of the AD2000 study]
    Thomas Kaiser
    Institut für Qualität undWirtschaftlichkeit im Gesundheitswesen, Koln
    Med Klin (Munich) 100:157-60. 2005
  5. ncbi request reprint Influence of nebivolol and enalapril on metabolic parameters and arterial stiffness in hypertensive type 2 diabetic patients
    Thomas Kaiser
    Institute for Quality and Efficiency in Health Care, Cologne, Germany
    J Hypertens 24:1397-403. 2006
  6. ncbi request reprint [Evaluation of an internal guideline for the diagnostics of deep vein thrombosis]
    Andreas Waltering
    DIeM Institut für evidenzbasierte Medizin, Koln
    Med Klin (Munich) 102:612-6. 2007
  7. ncbi request reprint [Practical evidence-based medicine]
    Peter T Sawicki
    Z Arztl Fortbild Qualitatssich 97:249-50. 2003
  8. ncbi request reprint [Institute for Quality and Efficiency in Health Care. Goals and tasks]
    Peter T Sawicki
    Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen, Koln
    Med Klin (Munich) 100:155-6. 2005
  9. ncbi request reprint [Coronary heart disease patient reaches LDL level of 100 mg/dl with atorvastatin: how do you continue treatment next year?]
    Achim Weizel
    Diakoniekrankenhaus Mannheim
    MMW Fortschr Med 146:14, 16. 2004
  10. ncbi request reprint Kidney function during and after withdrawal of long-term irbesartan treatment in patients with type 2 diabetes and microalbuminuria: response to Andersen, Brochner-Mortensen, and Parving
    Thomas Kaiser
    Diabetes Care 27:1521; author reply 1521-2. 2004

Collaborators

Detail Information

Publications13

  1. ncbi request reprint Have ALLHAT, ANBP2, ASCOT-BPLA, and so forth improved our knowledge about better hypertension care?
    Peter T Sawicki
    Institute for Quality and Efficiency in Health Care, Cologne, Germany
    Hypertension 48:1-7. 2006
  2. ncbi request reprint [Assessment of the number of cardio- and cerebrovascular events due to rofecoxib (Vioxx) in Germany between 2001 and 2004]
    Peter T Sawicki
    Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen IQWiG, Koln
    Med Klin (Munich) 101:191-7. 2006
    ....
  3. ncbi request reprint [Quality of health care in Germany. A six-country comparison]
    Peter T Sawicki
    Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen IQWiG, Koln
    Med Klin (Munich) 100:755-68. 2005
    ..Females are less likely than males to rate their overall care as excellent or very good...
  4. ncbi request reprint [Donepezil in patients with Alzheimer's disease--a critical appraisal of the AD2000 study]
    Thomas Kaiser
    Institut für Qualität undWirtschaftlichkeit im Gesundheitswesen, Koln
    Med Klin (Munich) 100:157-60. 2005
    ..Long-term-randomized controlled trials focusing on patient-relevant outcomes instead of cognitive scores are urgently needed...
  5. ncbi request reprint Influence of nebivolol and enalapril on metabolic parameters and arterial stiffness in hypertensive type 2 diabetic patients
    Thomas Kaiser
    Institute for Quality and Efficiency in Health Care, Cologne, Germany
    J Hypertens 24:1397-403. 2006
    ....
  6. ncbi request reprint [Evaluation of an internal guideline for the diagnostics of deep vein thrombosis]
    Andreas Waltering
    DIeM Institut für evidenzbasierte Medizin, Koln
    Med Klin (Munich) 102:612-6. 2007
    ....
  7. ncbi request reprint [Practical evidence-based medicine]
    Peter T Sawicki
    Z Arztl Fortbild Qualitatssich 97:249-50. 2003
  8. ncbi request reprint [Institute for Quality and Efficiency in Health Care. Goals and tasks]
    Peter T Sawicki
    Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen, Koln
    Med Klin (Munich) 100:155-6. 2005
  9. ncbi request reprint [Coronary heart disease patient reaches LDL level of 100 mg/dl with atorvastatin: how do you continue treatment next year?]
    Achim Weizel
    Diakoniekrankenhaus Mannheim
    MMW Fortschr Med 146:14, 16. 2004
  10. ncbi request reprint Kidney function during and after withdrawal of long-term irbesartan treatment in patients with type 2 diabetes and microalbuminuria: response to Andersen, Brochner-Mortensen, and Parving
    Thomas Kaiser
    Diabetes Care 27:1521; author reply 1521-2. 2004
  11. ncbi request reprint Systematic review of studies of self-management of oral anticoagulation
    Andrea Siebenhofer
    Department of Internal Medicine, Karl Franzens University Hospital, A 8036 Graz, Austria
    Thromb Haemost 91:225-32. 2004
    ..Patients' self-management is safe and can improve the quality of anticoagulation control, however, no valid long term study has yet actually demonstrated reduction of bleeding and thromboembolic events...
  12. ncbi request reprint Acarbose for patients with hypertension and impaired glucose tolerance
    Thomas Kaiser
    JAMA 290:3066; author reply 3067-9. 2003
  13. ncbi request reprint A randomized trial comparing INR monitoring devices in patients with anticoagulation self-management: evaluation of a novel error-grid approach
    Lars G Hemkens
    DIeM Institute for Evidence Based Medicine, Venloer Str 301 303, 50823 Cologne, Germany
    J Thromb Thrombolysis 26:22-30. 2008
    ..Two anticoagulation monitors were compared in a real-life setting and a novel error-grid instrument for oral anticoagulation has been evaluated...